The firm is expanding its melanoma portfolio while launching new trials of T-cell receptor therapies in oncology, infectious disease, and autoimmune disease.

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

Radiation testing suggests that solar cells made from carbon-based, or organic, materials could outperform conventional ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

Air Industries Group has secured a contract valued at $5.9m to supply flight control assemblies for the US Air Force's (USAF) ...

Linkind's ET8 Matter Smart TV backlights bring your content to life. Having used similar products to Linkind's ET8 Matter ...